Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
August 26th, 2020
4.9K views
High resolution melting analysis (HRM) is a sensitive and rapid solution for genetic variant detection. It depends on sequence differences that result in heteroduplexes changing the shape of the melting curve. By combing HRM and agarose gel electrophoresis, different types of genetic variants such as indels can be identified.
Tadej Pajič 1,2, Tanja Belčič Mikič1, Helena Podgornik1,3, Jurka Klun1, Sandra Šućurović1,
View the full transcript and gain access to thousands of scientific videos
Overview
High resolution melting analysis (HRM) is a rapid method for detecting genetic variants, particularly effective in identifying calreticulin mutations in patients with hematologic conditions. This technique combines HRM with agarose gel electrophoresis to distinguish various genetic variants.
Key Study Components
Area of Science
- Genetic variant detection
- Hematology
- Diagnostic techniques
Background
- Calreticulin mutations are significant in myeloproliferative disorders.
- HRM provides a noninvasive diagnostic option.
- Other diagnostic methods may be limited in certain cases.
- Cost-effectiveness is a notable advantage of this technique.
Purpose of Study
- To accurately define calreticulin mutations.
- To facilitate rapid diagnosis of essential thrombocythemia and primary myelofibrosis.
- To explore the potential future impact on therapy choices.
Methods Used
- Preparation of qPCR HRM master mix.
- Conducting HRM analysis for DNA samples.
- Utilizing agarose gel electrophoresis for variant identification.
- Performing multiple replicates for accuracy.
Main Results
- Successful identification of common somatic genetic variants.
- HRM demonstrated an acceptable limit of detection.
- Rapid and noninvasive diagnosis was achieved.
- No immediate effect on therapy choices was noted.
Conclusions
- HRM is a valuable tool for detecting calreticulin mutations.
- The method holds promise for future diagnostic applications.
- Continued research may influence treatment strategies.
Frequently Asked Questions
What is high resolution melting analysis?
HRM is a technique used to detect genetic variants by analyzing the melting behavior of DNA.
How does HRM work?
HRM detects differences in DNA sequences that affect melting curves, indicating the presence of mutations.
What are calreticulin mutations?
Calreticulin mutations are genetic changes associated with certain blood disorders, particularly myeloproliferative neoplasms.
What conditions can HRM help diagnose?
HRM is particularly useful for diagnosing essential thrombocythemia and primary myelofibrosis.
Is HRM cost-effective?
Yes, HRM is considered an affordable method for genetic variant detection.
Will HRM affect treatment choices?
Currently, HRM does not influence treatment decisions, but this may change with further research.
Executive Industry Relevance
High resolution melting analysis (HRM) enables rapid, cost-effective detection of somatic genetic variants in the CALR gene, supporting early diagnosis of myeloproliferative neoplasms when other methods are limited. This approach provides a noninvasive, accessible tool for target validation in hematologic oncology discovery workflows, particularly where JAK2 V617F-negative patients require alternative biomarker screening. By combining HRM with agarose gel electrophoresis, the method improves variant discrimination in indel-prone regions, enhancing predictive confidence in preclinical target validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by detecting CALR mutations in JAK2 V617F-negative MPN patients, clarifying disease-relevant genetic drivers.
- Operational Value: Supports functional target validation through rapid genotyping of somatic variants in the CALR hotspot region using affordable, accessible qPCR-based HRM.
- Predictive Value: Improves target confidence by distinguishing wild-type from mutant alleles via melt curve analysis, reducing false positives in early target identification.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by confirming genetic variant status in patient-derived samples prior to compound testing.
- Operational Value: Enables assay standardization through replicate-controlled HRM runs and agarose gel confirmation, improving reproducibility across sample sets.
- Scalability Value: Facilitates platform reuse in genetic screening workflows due to low cost, minimal sample input, and compatibility with standard qPCR instruments.
Translational & Preclinical Research
- Translational Value: Connects discovery-phase variant detection to preclinical continuity by identifying CALR mutations relevant to essential thrombocythemia and primary myelofibrosis models.
- Risk-Adjusted Advancement: Supports go/no-go decisions by providing genetic stratification of MPN subtypes, enabling biomarker-aligned preclinical study design.
- Mechanistic De-risking: Reduces ambiguity in target validation by distinguishing common somatic variants from rare variants using orthogonal HRM and gel electrophoresis confirmation.
Pipeline & Workflow Integration
HRM fits within the discovery continuum from target validation through lead identification, enabling early genetic stratification of patient samples before compound screening in hematologic oncology programs.
- Discovery Biology: Supports hypothesis testing and pathway clarification by detecting CALR mutations that define molecular subtypes of myeloproliferative neoplasms.
- Screening: Enables assay readiness through quantitative melt curve analysis and gel-based variant confirmation, ensuring reliable compound evaluation in genetically defined cohorts.
- Analytics: Generates quantitative dependent variable measurements (melting temperature shifts, curve shapes) that allow comparison of genetic variants across samples and controls.
- Translational Research: Connects to preclinical continuity by identifying CALR mutations with known phenotypic relevance in MPN models, supporting biomarker-aligned validation.
- Enterprise Reuse: Functions as a reusable genotyping capability across discovery projects due to low cost, minimal training, and compatibility with existing qPCR infrastructure.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity through accurate detection of CALR somatic variants.
- Operational Value: Enhances standardization and reproducibility via controlled qPCR HRM protocols and orthogonal gel electrophoresis confirmation.
- Strategic Value: Improves capital efficiency by enabling early go/no-go decisions based on genetic stratification, reducing investment in non-responsive targets.
- Portfolio Impact: Supports risk-adjusted prioritization by identifying CALR-mutant subgroups with higher likelihood of target engagement in preclinical models.
Implementation Considerations
- Requires expertise in qPCR setup, melt curve analysis, and agarose gel electrophoresis for variant confirmation.
- Dependent on high-resolution melt capable instruments and specialized software for accurate curve alignment and difference plotting.
- Necessitates cross-team standardization of control samples (wild-type, mutant, NTC) to ensure consistent variant calling across sites.
- Requires adaptation when product length increases, as heteroduplex resolution decreases, necessitating gel electrophoresis for indel discrimination.
- Limited by the need for Sanger sequencing confirmation in cases of inconclusive HRM and gel results, particularly for rare variants.
Biopharma FAQs
Why does melt curve analysis matter for CALR variant detection?
Melt curve analysis detects small differences in DNA sequence that alter melting behavior, enabling distinction between wild-type and mutant CALR alleles in HRM assays.
How does isolating the wild-type control as reference improve variant calling?
Using a wild-type control as reference in difference plot analysis aligns sample melt curves to highlight deviations caused by genetic variants, improving detection accuracy.
What quantitative measurements enable reliable variant discrimination in HRM?
Melting temperature shifts and curve shape differences in aligned melt plots provide quantitative outputs for comparing unknown samples to known genotype controls.
Why are replication requirements important for HRM-based genotyping?
Replicates ensure amplification consistency and reduce false variant calls by confirming that melt curve patterns are reproducible across multiple wells.
What statistical analysis is needed before implementing HRM for variant screening?
Baseline threshold setting, exponential phase verification, and NTC contamination checks are required to ensure valid qPCR amplification before melt curve analysis.
